Recent Media

Longeviti is an authority on advanced neurosurgical implantation of technology, through the development of low-profile intracranial implants that address the functional and reconstructive needs of patients with neurological conditions. Since 2018, the company has brought several FDA-cleared implants to market. Longeviti’s mission is to develop innovative solutions for complex brain surgery that return patients to anatomical normalcy.

Date
Recent news

Industry Insights

"Neuro technology has not kept pace with other medical innovations. There isn’t a part of the body or an organ that can’t be replaced. Now is the time to bring this same spirit of innovation to the brain."
— Jesse Christopher
Longeviti CEO
"Longeviti builds implants today designed for the technology of tomorrow."
— Jesse Christopher
Longeviti CEO
"Physicians and hospitals systems are increasingly recognizing the need for multidisciplinary collaboration in caring for neurosurgical patients."
— Jesse Christopher
Longeviti CEO
"There is a tremendous amount of responsibility in bringing these technologies to market. Putting batteries in the head requires humanitarian pathways and use cases."
— Jesse Christopher
Longeviti CEO
"This isn’t about living longer. It is about building technology that enables humans to stay themselves for longer."
— Jesse Christopher
Longeviti CEO